Search Filters

Search Results

Found 6 results

510(k) Data Aggregation

    K Number
    K183066
    Date Cleared
    2019-07-25

    (262 days)

    Product Code
    Regulation Number
    870.1340
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The POWERWAND™ Safety Introducer with an Extended Dwell Catheter made of ChronoFlex C® with BioGUARD™ Technology is used to gain access to the vascular system to sample blood and administer fluids intravenously. It may be used for power injection of contrast media up to a rate of 8 ml/sec and at a maximum of 325 psi fluid pressure.

    Device Description

    The POWERWAND™ Safety Introducer with an Extended Dwell Catheter made of ChronoFlex C® with BioGUARD™ Technology is an all-in-one preassembled device that combines the functionality of a catheter introducer system with an extended dwell (

    AI/ML Overview

    The provided text is a 510(k) summary for a medical device (The POWERWAND™ Safety Introducer with an Extended Dwell Catheter) and focuses on demonstrating substantial equivalence to a predicate device. It is not a study proving the device meets acceptance criteria for a performance evaluation in the way a clinical study or AI/Machine Learning model validation would be described.

    Therefore, many of the requested elements (acceptance criteria table, sample sizes, expert qualifications, MRMC studies, standalone performance, training set details, etc.) are not applicable to this type of regulatory submission and information provided.

    The document discusses "pre-clinical thrombogenicity tests" to support a labeling claim, but it does not provide the details of these tests in a format that would allow for filling out the requested table or answering questions about sample sizes, adjudication, or ground truth establishment relevant to an AI/ML or diagnostic device performance study.

    Here's a breakdown of what can be extracted and what cannot:

    Information that can be extracted:

    • Type of Study: This is a 510(k) submission primarily focused on demonstrating substantial equivalence to a predicate device, with some pre-clinical testing for a thrombogenicity labeling claim. It is not a clinical trial or AI/ML performance study.
    • Sample size for training set: Not applicable (N/A) as this is not an AI/ML device.
    • How ground truth for training set was established: N/A as this is not an AI/ML device.

    Information that cannot be extracted or is not applicable to this document's content:

    1. Table of acceptance criteria and reported device performance: The document states that "A series of pre-clinical thrombogenicity tests were conducted to support a thrombogenicity labeling claim." However, it does not provide specific acceptance criteria values (e.g., "Thrombus formation less than X%") or the quantitative results of these tests. It only states that the device "has shown in vivo to be thromboresistant."
    2. Sample sizes used for the test set and the data provenance: The document mentions "72-hour canine jugular vein thromboresistance studies" for the pre-clinical tests, indicating an animal model. However, it does not specify the number of animals or data provenance (e.g., specific country, retrospective/prospective).
    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable. For the pre-clinical thrombogenicity tests, "ground truth" would likely be based on pathological/histological analysis, not expert radiology reads.
    4. Adjudication method for the test set: Not applicable.
    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This device is not an AI/ML diagnostic or assistive tool.
    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable.
    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.): For the thrombogenicity tests, it implies pathology/histology ("thrombus on the surface of the catheter and thrombus on the wall of the vein"). For the rest of the 510(k), it's a comparison to a predicate device based on device characteristics and indications for use.

    In summary, the provided document details a regulatory submission for substantial equivalence of a medical device, including some pre-clinical animal testing for a specific claim. It does not contain the detailed performance data or study design typically associated with validating a diagnostic device or AI/ML product against specific acceptance criteria.

    Ask a Question

    Ask a specific question about this device

    K Number
    K181563
    Date Cleared
    2018-09-26

    (104 days)

    Product Code
    Regulation Number
    870.1250
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The ARTERIAL WAND™ Safety Introducer with Arterial Catheter made of ChronoFlex C® with BioGUARD™ Technology is used to gain access to the vascular (e.g. arterial) system to sample blood, administer fluids, and monitor blood pressure intravascularly.

    Device Description

    The ARTERIAL WAND™ Safety Introducer with Arterial Catheter made of ChronoFlex C® with BioGUARD™ Technology is an all-in-one preassembled device that combines the functionality of a catheter introducer system with an arterial catheter. The ARTERIAL WAND™ is used to gain access to the vascular (e.g. arterial) system to insert the arterial catheter. The arterial catheter may then be left in place for a period of

    AI/ML Overview

    I am sorry but this document does not contain the information required to answer your request. This document is related to a Medical Device Application for a catheter, and the questions are related to AI/ML device testing.

    Ask a Question

    Ask a specific question about this device

    K Number
    K182243
    Date Cleared
    2018-09-18

    (29 days)

    Product Code
    Regulation Number
    870.1340
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The CVC WAND™ Safety Introducer with Valved Peelable Sheath is indicated for use in percutaneous insertion of catheters into the venous system.

    Device Description

    The CVC WAND™ Safety Introducer with Valved Peelable Sheath (hereafter CVC WAND™) is a catheter introducer device that is virtually identical to the predicate device, the CVC WAND™ Safety Introducer with Valved Peelable Sheath, cleared for commercial distribution under 510(k) K131148. When assembled for use, it is an all-inone preassembled intravascular catheter introducer, that provides the clinician with a simple and accelerated approach to the Seldinger Technique for placing in-dwelling intravascular catheters. The device is composed of the following key components:

    • Introducer Needle
    • Guidewire
    • Dilator
    • Valved Peelable Sheath Introducer

    The CVC WAND™ includes a 21-gauge microaccess needle, nylon tissue dilator, FEP peelable sheath and Nitinol guidewire. This device has an integrated valve within the body of the Peelable Sheath Introducer hub which is designed to reduce inflow of air into the bloodstream and outflow of blood when the guidewire, introducer needle and dilator are removed, but it is not a hemostasis valve. The device also has a blood flashback window proximal to the needle's tip which allows the clinician to observe blood flashback upon entering the vessel with the Safety Introducer. The microaccess needle is echogenic and provides the pathway for the guidewire insertion, while the dilator facilitates placement of the peelable sheath and ultimately catheter placement.

    The CVC WAND™ is individually packaged in a PETG. glvcol modified polyethylene terephthalate, plastic tray. The tray is heat sealed with a Tyvek® lid. The device is provided 'STERILE' (ethylene oxide gas) and is for 'single-use' only.

    AI/ML Overview

    The FDA 510(k) summary for "The CVC WAND Safety Introducer with Valved Peelable Sheath" (K182243) does not describe a study involving AI or human readers. The summary focuses on validating a material change in a component of the device (from silicone to thermoplastic elastomer in the valve of the peelable sheath introducer) and demonstrating its substantial equivalence to a previously cleared predicate device (K131148). Therefore, many of the requested categories are not applicable to this submission.

    Here's a breakdown of the information provided based on your request, with an emphasis on what is not applicable due to the nature of the device and the submission:

    1. A table of acceptance criteria and the reported device performance

    The document describes various tests conducted and generally states that the results "satisfied the acceptance criteria of the relevant ISO 10993 standards" or "satisfy acceptance criteria identified in applicable standards and/or the device design specification." However, specific numerical acceptance criteria or detailed performance metrics are not explicitly provided in a table format as requested. The document primarily lists the tests performed and a high-level outcome of meeting criteria.

    Test CategorySpecific Tests MentionedReported Device Performance
    Biocompatibility (New Material)- Cytotoxicity (ISO 10993-5:2009)Satisfied acceptance criteria of relevant ISO 10993 standards. (GLP conducted for applicable tests)
    - Sensitization (ISO 10993-10:2010)
    - Intracutaneous Reactivity (ISO 10993-10:2010)
    - Acute Systemic Toxicity (ISO 10993-11:2006)
    - Hemolysis (ASTM, ISO 10993-4:2002)
    - Material Mediated Pyrogenicity (ISO 10993-11:2006)
    - Partial Thromboplastic Time (PTT) (ISO 10993-4:2002)
    - In Vitro Platelet and Leucocyte Counts (ISO 10993-4:2002)
    - Complement Activation (ISO 10993-4:2002)
    Performance Testing (New Valve)- Valve Air LeakageSatisfied acceptance criteria identified in applicable standards and/or device design specification.
    - Valve Liquid Leakage
    - Valve Flexibility
    - Valve Patency
    - Valve Integrity
    Device System Testing- Particulate Matter USP (Reference only)Satisfied acceptance criteria identified in applicable standards and/or device design specification.
    Leveraged Predicate TestingLumen patency, Tensile strength, Air leak, Corrosion resistance, Distal Tip Columnar Strength, Strength of Union, Fracture testing, Flex testing, Axial Forces, "Fast-Flash™" Evaluation, Insertability, Needle-stick safety, Guidewire cap snap-on force, Protective Cover Removal Force, Needle lock to Needle hub separation force.Results from the predicate device (K131148) were considered acceptable and leveraged as these aspects were not affected by the material change in the valve.

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    • Sample Size: Not explicitly stated for any of the individual tests. The submission describes conducting "designed verification testing."
    • Data Provenance: The document indicates that tests were conducted according to ISO and ASTM standards, and some were GLP (Good Laboratory Practice) compliant. This suggests controlled laboratory settings. It doesn't specify a country of origin for the data or whether the data was retrospective or prospective, though performance testing is inherently prospective for the device being tested.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    This is not applicable. The device is a medical instrument (catheter introducer), not a diagnostic imaging device or an AI algorithm requiring expert ground truth for its performance assessment. Its performance is evaluated through physical, chemical, and biological tests against established standards.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    This is not applicable. See the explanation for point 3.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This is not applicable. This device is a physical medical instrument, not an AI system.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    This is not applicable. This device is a physical medical instrument, not an AI algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    For the biocompatibility and performance testing, the "ground truth" or reference for comparison are established international standards (ISO, ASTM, USP) and the device's own design specifications for functional requirements. For example, for biocompatibility, the reference is what constitutes a non-toxic or non-irritating response according to ISO 10993. For mechanical tests, it's meeting specified engineering tolerances.

    8. The sample size for the training set

    This is not applicable. This is a physical medical device, not an AI system with a training set.

    9. How the ground truth for the training set was established

    This is not applicable. See the explanation for point 8.

    In summary, the K182243 submission focuses on demonstrating the safety and performance of a modified medical device through standard engineering and biocompatibility testing, rather than the evaluation of an AI-powered diagnostic tool. Therefore, many of your questions related to AI studies and their methodologies are not relevant to this particular FDA submission.

    Ask a Question

    Ask a specific question about this device

    K Number
    K162322
    Date Cleared
    2016-11-17

    (90 days)

    Product Code
    Regulation Number
    870.1340
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The POWERWAND® Safety Introducer with an Extended Dwell Catheter is used to gain access to the vascular system to sample blood and administer fluids intravenously. It may be used for power injection of contrast media up to a rate of 8 ml/sec and at a maximum of 325 psi fluid pressure.

    Device Description

    The POWERWAND® Safety Introducer with an Extended Dwell Catheter is an all-in-one preassembled intravascular catheter introducer with intravascular catheter that consists of the following principle components: Introducer Needle, Guidewire, Dilator and an Extended Dwell Catheter. It is intended to provide the clinician with a safe, simple and accelerated approach, using the Accelerated Seldinger Technique, to place an in-dwelling intravascular catheter through the skin into the circulatory system. The Extended Dwell Catheter allows for withdrawal of blood and the administration of fluids, including power injection of contrast media. The device also incorporates a mechanism that provides passive needle stick safety.

    AI/ML Overview

    The provided text describes a 510(k) premarket notification for a medical device called the POWERWAND® Safety Introducer with an Extended Dwell Catheter (3 Fr Model). This device is substantially equivalent to a predicate device and does not involve AI or algorithms, and therefore does not have acceptance criteria or a study design in the context of an AI/ML device.

    However, I can extract information related to the device's performance testing to demonstrate its equivalence to the predicate device and satisfaction of product design specifications.

    Here's a breakdown of the information that can be extracted, framed as device performance rather than AI acceptance criteria:

    1. Table of Acceptance Criteria and Reported Device Performance:

    The document doesn't provide a formal "acceptance criteria" table in the AI/ML sense, but it lists various performance tests conducted. For a traditional medical device, these tests are designed to demonstrate that the device meets its design specifications and is safe and effective for its intended use. The Reported Device Performance column would generally indicate that the device passed or met the requirements for each test.

    Component / CharacteristicTestingReported Device Performance (Implied)
    24 Gauge NeedleStrength of union between needle hub and needle tubeMet specifications
    24 Gauge NeedleResistance to BreakageMet specifications
    DilatorDilator Column StrengthMet specifications
    DilatorStrength of Union (Hub to Tube)Met specifications
    3 Fr IV Catheter – Standard TestingCollapse PressureMet specifications
    3 Fr IV Catheter – Standard TestingCatheter Column StrengthMet specifications
    3 Fr IV Catheter – Standard TestingFlowrateMet specifications
    3 Fr IV Catheter – Standard TestingCatheter Force at BreakMet specifications
    3 Fr IV Catheter – Standard TestingPriming VolumeMet specifications
    3 Fr IV Catheter – (continued)Burst PressureMet specifications
    3 Fr IV Catheter – (continued)Freedom from LeakageMet specifications
    3 Fr IV Catheter – (continued)Chemical CompatibilityMet specifications
    3 Fr IV Catheter – Testing after Pre-ConditioningBending FatigueMet specifications
    3 Fr IV Catheter – Testing after Pre-ConditioningPower Injection (up to a rate of 8 ml/sec and at a maximum of 325 psi fluid pressure)Met specifications (as per Indications)
    3 Fr IV Catheter – Testing after Pre-ConditioningBurst PressureMet specifications
    Introducer SystemAxial ForcesMet specifications
    Introducer SystemFast-flash™ EvaluationMet specifications
    Introducer SystemInsertabilityMet specifications
    Introducer SystemNeedle-Stick safetyMet specifications
    Introducer SystemIntraluminal Positioning Visual IndicatorsMet specifications
    Introducer SystemPM ContentMet specifications

    2. Sample Size Used for the Test Set and Data Provenance:

    • Test Set Sample Size: The document does not specify the exact sample sizes (N) for each individual test conducted. It generically refers to "Prospective testing conducted for the 3 Fr Model POWERWAND®."
    • Data Provenance: The document does not indicate the country of origin of the data or whether it was retrospective or prospective in the clinical sense. However, the testing indicated ("Prospective testing conducted for the 3 Fr Model POWERWAND®") implies that the tests were carried out on newly manufactured 3 Fr Model devices (i.e., prospective device testing, not clinical data provenance).

    3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications:

    • Not Applicable. This is a physical medical device clearance, not an AI/ML device requiring expert ground truth for image interpretation or diagnosis. The "ground truth" for these performance tests is based on engineering specifications and physical measurements.

    4. Adjudication Method for the Test Set:

    • Not Applicable. As this is not an AI/ML device, there is no need for adjudication of results by multiple experts. Device performance is determined by meeting pre-defined engineering and safety specifications through objective measurements.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done:

    • No, an MRMC study was not done. This type of study is relevant for AI/ML diagnostic devices where human readers' performance is compared with and without AI assistance. This device is an introducer with a catheter; it's a tool for medical procedures, not a diagnostic AI.

    6. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) Was Done:

    • Not Applicable. This device does not have an algorithm or AI component. Therefore, standalone algorithm performance is not relevant.

    7. The Type of Ground Truth Used:

    • Engineering Specifications and Physical Measurements. For each test (e.g., strength of union, flow rate, burst pressure), the "ground truth" is established by the documented design specifications and industry standards for medical devices of this type. The device's performance is measured against these objective criteria using calibrated equipment.

    8. The Sample Size for the Training Set:

    • Not Applicable. This device is not an AI/ML device and therefore does not have a "training set" in the context of machine learning.

    9. How the Ground Truth for the Training Set Was Established:

    • Not Applicable. Since there is no training set for an AI/ML model, the concept of establishing ground truth for it is irrelevant for this traditional medical device.
    Ask a Question

    Ask a specific question about this device

    K Number
    K131148
    Date Cleared
    2013-09-04

    (134 days)

    Product Code
    Regulation Number
    870.1340
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The CVC WAND™ Safety Introducer with Valved Peelable Sheath is indicated for use in percutaneous insertion of catheters into the venous system.

    Device Description

    The CVC WAND™ Safety Introducer with Valved Peelable Sheath (hereafter CVC WAND™) is a catheter introducer device that is virtually identical to the predicate device. the PICC WAND® Peelable Safety Introducer (K111138). When assembled for use, it is an all-in-one preassembled intravascular catheter introducer, that provides the clinician with a safe, simple, and accelerated approach to the Seldinger Technique for placing in-dwelling intravascular catheters. The device is composed of the following key components:

    • Introducer Needle
    • Guidewire
    • Dilator
    • Valved Peelable Sheath Introducer
      Some of the components of the predicate device have been modified to facilitate the specific clinical requirements for peripheral access for the placement of a Central Venous Catheter (CVC). The primary modification to the predicate device is the addition of a valve within the body of the Peelable Sheath Introducer Hub. When the Guidewire, Needle and Dilator are removed from the Valved Peelable Sheath Introducer, as part of performing the Accelerated Seldinger Technique procedure, the valve in the hub is actuated (in the closed position) thus preventing air from entering into the venous circulatory system and conversely preventing blood from leaking out. The valve is designed to allow passage of the CVC through it into the central venous circulatory system. This valve provides a similar function as the Bard AirGuard™ Valved Introducer, the other predicate device (K042036). After confirmation of the proper CVC placement, the Valved Peelable Sheath Introducer is removed by breaking apart the Sheath Introducer hub and peeling the sheath off the CVC in the identical manner as the predicate PICC WAND® Peelable Sheath Introducer.
      The CVC WAND™ Safety Introducer is individually packaged in a PETG, glycol modified polyethylene terephthalate, plastic tray. The tray is heat sealed with a Tyvek® lid. The device is provided 'STERILE'(ethylene oxide gas) and is for 'single-use` only.
    AI/ML Overview

    Here's a breakdown of the acceptance criteria and study information for the CVC WAND™ Safety Introducer with Valved Peelable Sheath, based on the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance

    The provided text outlines the types of tests performed and states that the results "satisfied acceptance criteria as identified in applicable standards and the device design specification." However, it does not provide specific numerical acceptance criteria or the reported device performance metrics for these tests. It only lists the tests themselves.

    Here's a table summarizing the tests, categorizing them implicitly based on the context:

    CategoryAcceptance Criteria (Not explicitly stated, assumed to be passing relevant standards)Reported Device Performance (Not explicitly stated beyond "satisfied acceptance criteria")
    Biocompatibility TestingPassing all relevant provisions of ISO 10993 standardsResults satisfied the acceptance criteria of the relevant ISO 10993 standards
    Component-Specific Testing (Valved Peelable Sheath Introducer - Prospective)Passing relevant design specifications and standards for each test parameterResults satisfied the acceptance criteria as identified in applicable standards and the device design specification
    - Distal Tip Columnar Strength
    - Strength of Union: Tube-to-Hub, Valve-to-Lower-Hub
    - Split/Peel Force of Hub/Sheath
    - Valve Flexibility/Patency
    - Valve Integrity
    - Valve Liquid Leakage
    - Valve Air Leakage
    System-Level Testing (Introducer System - Prospective)Passing relevant design specifications and standards for each test parameterResults satisfied the acceptance criteria as identified in applicable standards and the device design specification
    - Axial Forces
    - "Fast-flash™" Evaluation
    - Insertability
    - Protective Cover Removal Force – Dilator, Sheath Introducer
    - Needle Cover Functional Evaluation and Removal Force
    - Needle Cover Silicone Migration Evaluation
    - Particulate Matter

    2. Sample Sizes Used for the Test Set and Data Provenance

    The document does not explicitly state the sample sizes (number of units) used for the prospective bench testing (Table 5.3) or the biocompatibility testing (Table 5.1).

    Data provenance is not mentioned beyond the fact that the tests were conducted. There's no indication of country of origin or whether the studies were retrospective or prospective, though the term "Prospective testing" is used for the performance testing in Table 5.3.

    3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications

    This information is not applicable to the provided document. The studies described are bench tests and biocompatibility tests, not clinical studies involving expert assessment of images or patient data to establish ground truth.

    4. Adjudication Method for the Test Set

    This information is not applicable. Adjudication methods like 2+1 or 3+1 are typically used in clinical studies where expert consensus is needed to establish ground truth for a test set, which is not the case here.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    No MRMC comparative effectiveness study was mentioned. The studies focus on device performance characteristics and biocompatibility, not on the comparative effectiveness of human readers with or without AI assistance.

    6. Standalone (Algorithm Only) Performance

    This information is not applicable. The device is a physical medical introducer, not an AI algorithm.

    7. Type of Ground Truth Used

    The "ground truth" for the tests performed can be considered the established scientific/engineering principles, validated test methods (e.g., ISO standards), and the device design specifications. For example:

    • For biocompatibility, the ground truth is that the device material should not elicit adverse biological reactions as defined by ISO 10993.
    • For performance tests like "Valve Liquid Leakage," the ground truth would be that the valve should prevent leakage beyond a specified (but unstated) limit.

    8. Sample Size for the Training Set

    This information is not applicable. There is no AI component mentioned, and thus no "training set" in the context of machine learning. The studies described are physical device testing.

    9. How Ground Truth for the Training Set Was Established

    This information is not applicable, as there is no training set for an AI/algorithm.

    Ask a Question

    Ask a specific question about this device

    K Number
    K131300
    Date Cleared
    2013-06-07

    (31 days)

    Product Code
    Regulation Number
    870.1340
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The POWERWAND® Safety Introducer with an Extended Dwell Catheter is used to gain access to the vascular system to sample blood and administer fluids intravenously. May be used for power injection of contrast media at a rate of 5 ml/sec at up to 300 psi fluid pressure.

    Device Description

    The POWERWAND® Safety Introducer with an Extended Dwell Catheter is an all-in-one preassembled intravascular catheter introducer with intravascular catheter that consists of the following basic components: Introducer Needle, Nitinol Guidewire, Dilator and an Extended Dwell Catheter. It is intended to provide the clinician with a safe, simple and accelerated approach, using the Accelerated Seldinger Technique, to place an in-dwelling intravascular catheter through the skin into the circulatory system. The Extended Dwell Catheter allows for withdrawal of blood and the administration of fluids, including power injection of contrast media. The device also incorporates a mechanism that provides passive needle stick safety.

    AI/ML Overview

    The presented document describes the 510(k) premarket notification for the POWERWAND® Safety Introducer with an Extended Dwell Catheter. This submission is for a modified device with a change in the material of the female Luer hub from Pellathane® (polyurethane) to Makrolon® (polycarbonate). The aim of the submission is to demonstrate substantial equivalence to the predicate device, not to introduce a new AI-powered diagnostic or assistive tool.

    Therefore, many of the typical acceptance criteria and study aspects related to AI/ML devices (such as sample size for test/training sets, data provenance, number of experts, adjudication methods, MRMC studies, standalone performance, and ground truth types) are not applicable to this medical device submission.

    Here's an analysis based on the provided text, focusing on the device's performance through engineering verification testing:

    1. A table of acceptance criteria and the reported device performance

    The document does not explicitly state numerical acceptance criteria for each test. Instead, it describes "performance requirements" and "satisfies requirements of the product design specification," implying that the modified device met pre-defined internal benchmarks based on the predicate device's performance. The reported "performance" is that the device passed these tests and was found to be substantially equivalent to the predicate.

    Component / Test AreaSpecific Tests ConductedAcceptance Criteria (Implied)Reported Device Performance
    IV Catheter with Makrolon® Luer HubBiocompatibility testing in accordance with ISO 10993-1:2009Meets ISO 10993-1:2009 standards for biocompatibility.Passed (implied by "substantially equivalent" conclusion)
    IV Catheter with Makrolon® Luer Hub - Standard Performance Testing• Tensile Strength
    • Burst Pressure
    • Hub Gauging
    • Leakage Test - Liquid
    • Leakage Test - Air
    • Air Leakage during Aspiration
    • Hub Separation Force
    • Hub Unscrewing Force
    • Hub Ease of Assembly
    • Hub Resistance to Overriding
    • Hub Stress Cracking
    • Strain Relief Cover Tensile Test
    • Strain Relief Cover Flex TestMeets product design specifications and is equivalent to predicate device performance for each metric.Passed for all listed tests (implied by "substantially equivalent" conclusion)
    IV Catheter with Makrolon® Luer Hub - Testing after Pre-Conditioning• Visual Inspection
    • Burst PressureMaintains integrity and specified burst pressure after pre-conditioning, equivalent to predicate.Passed for all listed tests (implied by "substantially equivalent" conclusion)
    Introducer System• Dilator Hub to Catheter Hub Removal Torque
    • Dilator Hub to Catheter Hub Separation ForceMeets product design specifications and is equivalent to predicate device performance for these forces.Passed for all listed tests (implied by "substantially equivalent" conclusion)

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    • Sample Size: The document does not specify the sample size for any of the performance tests conducted. For device verification testing, sample sizes are typically determined by statistical methods or industry standards.
    • Data Provenance: The testing was "prospective" in the sense that it was conducted specifically for this submission to verify the new material. "TABLE 11.1: PROSPECTIVE TESTING OF THE POWERWAND®" indicates the testing was planned and executed for the modified device. The country of origin of the data is not specified, but the submitter is Access Scientific, LLC. (USA).

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    This question is not applicable. The device is a physical medical instrument, and its performance is assessed through engineering and bench testing, not through expert-evaluated clinical data or image interpretation. "Ground truth" in this context refers to the physical properties and performance characteristics measured against established standards or specifications, not expert consensus on medical findings.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    This question is not applicable. Adjudication methods like 2+1 or 3+1 refer to human expert review processes for clinical data, which were not part of this device's performance testing.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This question is not applicable. An MRMC study is relevant to AI/ML-driven diagnostic or assistive devices involving human readers (e.g., radiologists interpreting images). This submission is for a physical medical device (an introducer with a catheter) and does not involve AI or human readers for diagnosis.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    This question is not applicable. The device is a physical medical instrument and does not involve an algorithm working in "standalone" mode.

    7. The type of ground truth used (expert concensus, pathology, outcomes data, etc)

    The "ground truth" for this device's performance is based on established engineering and materials science standards, regulatory requirements (e.g., ISO 10993-1 for biocompatibility), and internal product design specifications derived from the predicate device's performance. It is not based on expert consensus, pathology, or outcomes data in the medical diagnostic sense.

    8. The sample size for the training set

    This question is not applicable. This is a modified physical medical device, not an AI/ML model that requires a training set.

    9. How the ground truth for the training set was established

    This question is not applicable. As this is not an AI/ML device, there is no training set or associated ground truth in that context.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1